Objective: The Yale-Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation (NE-YBOCS) is a valid and reliable scale used to evaluate the severity of skin picking disorder (SPD). This was a validity and reliability study of a Turkish version of the NE-YBOCS. Method: Eighty patients diagnosed with SPD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria were included the study. The patients completed a sociodemographic data form, as well as the Beck Depression Inventory, the Beck Anxiety Inventory, the Skin Picking Impact Scale, the Barratt Impulsiveness Scale, the Eysenck Personality Questionnaire Revised-Short Form, and a Turkish version of the NE-YBOCS for analysis of the findings. Results: Exploratory factor analysis and confirmatory factor analysis determined that a 3-factor structure explained 74.7% of the variance and that the factor loads of 10 items were sufficient and had good fit index values. Criterion validity analysis verified the correlation between the NE-YBOCS and the other scales. The internal consistency of the scale, subdimensions, and item-total correlation coefficients were sufficient. Conclusion: The results indicated that the Turkish NE-YBOCS can be used as reliable and valid instrument to assess SPD.
___
1. Odlaug BL, Grant JE. Pathological Skin Picking. In Grant JE, Stein DJ, Woods DW, Keuthen NJ editors. Trichotillomania, Skin Picking, and Other Body-Focused Repetitive Behaviors. First ed., Arlington: American Psychiatric Pub, 2012, 21-43.
2. American Psychiatric Association. Handbook for the Identification and Classification of Diseases in Psychiatry. Köroğlu E (Translation Editor). Revised Fourth ed., (DSM-IVTR). Ankara: Physicians Publication Association, 2001
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. (DSM-5) Washington (DC): American Psychiatric Association, 2013.
4. Arnold LM., Megan BA, Susan LM. 2001. ‘Psychogenic Excoriation: Clinical Features, Proposed Diagnostic Criteria, Epidemiology and Approaches to Treatment’. CNS Drugs 2001; 15:351-359.
5. Fruensgaard K. Neurotic excoriations. A controlled psychiatric examination. Acta Psychiatr Scand Suppl 1984; 312:1-52.
6. Neziroglu F, Rabinowitz D, Breytman A, Jacofsky M. Skin picking phenomenology and severity comparison. Prim Care Companion J Clin Psychiatry 2008; 10:306-312.
7. Ricketts EJ, Snorrason Í, Kircanski K, Alexander JR, Thamrin H, et al. A latent profile analysis of age of onset in pathological skin picking. Compr Psychiatry 2018; 87:46-52.
8. Grant JE, Redden SA, Leppink EW, Chamberlain SR. Trichotillomania and co-occurring anxiety. Compr Psychiatry 2017; 72:1-5.
9. Grant JE, Redden SA, Medeiros GC, Odlaug BL, Curley EE, Tavares H, et al. Trichotillomania and its clinical relationship to depression and anxiety. Int J Psychiatry Clin Pract 2017; 21:302- 306.
10. Grant JE, Chamberlain SR. Clinical correlates of symptom severity in skin picking disorder. Compr Psychiatry 2017; 78:25-30.
11. Yeo SK, Lee WK. The relationship between adolescents’ academic stress, impulsivity, anxiety, and skin picking behavior. Asian J Psychiatr 2017; 28:111-114.
12. Rufer M, Bamert T, Klaghofer R, Moritz S, Schilling L, Weidt S. Trichotillomania and emotion regulation: Is symptom severity related to alexithymia?. Psychiatry Res 2014; 218:161-165.
13. Wilhelm S, Keuthen NJ, Deckersbach T, Engelhard IM, Forker AE, Baer L, et al. Self-injurious skin picking: Clinical characteristics and comorbidity. J Clin Psychiatry 1999; 60:454-459.
14. Lochner C, Simeon D, Niehaus DJ, Stein DJ. Trichotillomania and skin‐picking: A phenomenological comparison. Depress Anxiety 2002; 15:83-86.
15. Arnold LM, Mutasim DF, Dwight MM, Lamerson CL, Morris EM, McElroy SL. An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol 1999; 19:15-8.
16. Keuthen NJ, Jameson M, Loh R, Deckersbach T, Wilhelm S, Dougherty DD. Open-label escitalopram treatment for pathological skin picking. Int Clin Psychopharmacol 2007; 22:268-74.
17. Grant JE, Odlaug BL, Kim SW. Lamotrigine treatment of pathologic skin picking: an open-label study. J Clin Psychiatry 2007; 68:1384-91.
18. Keuthen NJ, Wilhelm S, Deckersbach T, Engelhard IM, Forker AE, Baer L, et al. The Skin Picking Scale: Scale construction and psychometric analyses. J Psychosom Res 2001; 50:337-41.
19. Keuthen NJ, Deckersbach T, Wilhelm S, Engelhard I, Forker A, O'sullivan RL, et al. The Skin Picking Impact Scale (SPIS): Scale development and psychometric analyses. Psychosom 2001; 42:397-403.
20. Walther MR, Flessner CA, Conelea CA, Woods DW. The Milwaukee Inventory for the Dimensions of Adult Skin Picking (MIDAS): Initial development and psychometric properties. J Behav Ther Exp Psychiatry 2009; 40:127-35.
21. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011.
22. Aydin EP, Kenar JG, Altunay IK, Kaymak D, Özer ÖA, Karamustafalioglu KO. Repetitive Transcranial magnetic stimulation in the treatment of skin picking disorder: An exploratory trial. J ECT 2020; 36:60-65.
23. Bloch MR, Elliott M, Thompson H, Koran LM. Fluoxetine in pathologic skin-picking: open-label and double-blind results. Psychosomatics 2001; 42:314-319.
24. Grant JE, Odlaug BL, Chamberlain SR, Kim SW. A doubleblind, placebo-controlled trial of lamotrigine for pathologic skin picking: Treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol 2010; 30:396-403.
25. Grant JE, Chamberlain SR, Redden SA, Leppink EW, Odlaug BL, Kim SW. N-acetylcysteine in the treatment of excoriation disorder: A randomized clinical trial. JAMA Psychiatry 2016; 73:490-496.
26. Kenar JG, Aydin EP, Aker DA, Altunay IK, Ozer OA. Skin Picking Impact Scale: Reliability and validity study of Turkish version. Psychiatr Clin Psychopharmacol 2020; 30:415-422.
27. Hisli N. Validity and reliability of Beck Depression Inventory for university students. Turkish Journal of Psychology 1989; 23:3-13. 28. Ulusoy M, Sahin N, Erkman H. Turkish version of the Beck Anxiety Inventory: Psychometric Properties. J Cogn Psychother 1998; 12:28-35.
29. Gülec H, Tamam L, Turhan M, Karakis G, Zengin M, Stanford MS. Psychometric properties of the Turkish version of the Barratt Impulsiveness Scale-11. Bulletin of Clinical Psychopharmacology 2008; 18:251-258.
30. Karancı AN, Dirik G, Yorulmaz O. Validity and Reliability Study of Personality Questionnaire-Revised Abbreviated Form (EPQR-A) in Turkey. Turk J Psychiatry 2007; 18:1-8. [Turkish] 31. Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika 1965; 30:179-185.
32. Buyukozturk S. Factor analysis: Basic concepts and its use in scale development. Educational Administration: Theory and Practice 2002; 8:470-483. [Turkish]
33. Schumacker RE, Lomax RG. A Beginner's Guide To Structural Equation Modeling. Second ed., London:Lawrence Erlbaum Associates, 2004.
34. McKay D, Danyko S, Neziroglu F, Yaryura-Tobias JA. Factor structure of the Yale-Brown Obsessive-Compulsive Scale: A two dimensional measure. Behav Res Ther 1995; 33:865-869.
35. Tek C, Ulug B, Rezaki BG, Tanriverdi N, Mercan S, Demir B, et al. Yale-Brown Obsessive Compulsive Scale and US National Institute of Mental Health Global Obsessive Compulsive Scale in Turkish: Reliability and validity. Acta Psychiatr Scand 1995; 91:410-413.
36. Karakoc Y, Donmez L. Basic principles in scale development studies. Journal of Medical Educational World 2014; 13:39-49. [Turkish]
37. Yusuf C. Scientific research and biostatistical analysis methods with SPSS. Second ed., Seckin Publishing: İstanbul, 2015. [Turkish]